Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 117,387 | 101,595 | 124,331 | 130,371 | 139,472 |
| Cost of Goods | 63,912 | 65,580 | 31,085 | 32,101 | 32,583 |
| Gross Profit | 53,475 | 36,015 | 93,246 | 98,270 | 106,889 |
| Operating Expenses | 105,152 | 49,441 | 347,567 | 95,104 | 147,496 |
| Operating Income | -50,765 | -12,846 | -254,236 | 3,267 | -40,024 |
| Interest Expense | 15,977 | 15,979 | 16,847 | 17,256 | 18,300 |
| Other Income | 643 | -495 | 173 | -8,922 | 1,058 |
| Pre-tax Income | -66,099 | -29,320 | -270,910 | -22,911 | -57,266 |
| Income Tax | -8,000 | -30,692 | -115,197 | -8,659 | -20,706 |
| Net Income Continuous | -58,099 | 1,372 | -155,713 | -14,252 | -36,560 |
| Net Income Discontinuous | 3,857 | 379 | 5,360 | 186 | N/A |
| Net Income | $-54,242 | $1,751 | $-150,353 | $-14,066 | $-36,560 |
| EPS Basic Total Ops | -1.59 | 0.06 | -4.31 | -0.40 | -1.06 |
| EPS Basic Continuous Ops | -1.70 | 0.00 | -4.41 | -0.41 | -1.06 |
| EPS Basic Discontinuous Ops | 0.11 | 0.06 | 0.10 | 0.01 | N/A |
| EPS Diluted Total Ops | -1.59 | 0.06 | -4.31 | -0.40 | -1.06 |
| EPS Diluted Continuous Ops | -1.70 | 0.00 | -4.41 | -0.41 | -1.06 |
| EPS Diluted Discontinuous Ops | 0.11 | 0.06 | 0.10 | 0.01 | N/A |
| EBITDA(a) | $12,667 | $57,630 | $-220,887 | $38,361 | $-8,708 |